HM Payson & Co’s Meridian Bioscience Inc VIVO Stock Holding History

HM Payson & Co’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-810	Closed	-$7K	–	952
2020 Q1	$7K	Buy	+810	New	+$6.82K	﹤0.01%	786

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

HM Payson & Co's VIVO Position: Q2 2020 in Review

HM Payson & Co sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 810 shares — an estimated $7K sold.

HM Payson & Co first reported a position in VIVO in Q1 2020 and held it in 1 quarter. The position peaked at $7K in Q1 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

HM Payson & Co reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
HM Payson & Co sold 810 Meridian Bioscience Inc shares in Q2 2020, an estimated $7K.
HM Payson & Co first reported a position in Meridian Bioscience Inc in Q1 2020 and held it in 1 quarter.
HM Payson & Co's Meridian Bioscience Inc position peaked at $7K in Q1 2020.
191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on HM Payson & Co's 13F filing for Q2 2020, filed 13 Aug 2020.